Brian M. Frier|Marie Markert Jensen|Barrie Chubb
Hypoglycaemia in adults with insulin?treated diabetes in the <scp>UK</scp>: self?reported frequency and effects
The Queen's Medical Research Institute|University of Edinburgh|Novo Nordisk (Denmark)|Novo Nordisk (United Kingdom)
abstract aim reallife studies nonsevere selftreated hypoglycaemic events available survey quantified selfreported frequency nonsevere hypoglycaemia effects adults insulintreated diabetes uk methods adults aged gt 15 years type 1 diabetes insulintreated type 2 diabetes completed 4 weekly questionnaires 7day recall respondents type 2 diabetes grouped insulin regimen basalonly basalbolus results overall 1038 respondents 466 type 1 diabetes 572 type 2 diabetes completed 3528 questionnaires mean numbers nonsevere events per week 24 type 1 diabetes median 2 08 type 2 diabetes median 0 23 26 nonsevere events occurred night respectively fatigue reduced alertness commonest issues following events 78 51 respondents respectively effects nocturnal events persisted longer daytime events type 1 diabetes 106 vs 49 h p 00002 type 2 diabetes 153 vs 51 h p lt 00001 week following event respondents blood glucose measurements increased 43 type 1 diabetes 12 increment 42 type 2 diabetes 21 increment testsweek employed respondents 20 events caused worktime loss following nocturnal vs daytime hypoglycaemia type 1 diabetes 27 vs 11 h p 00184 type 2 diabetes 25 vs 16 h p 01340 respondents rarelynever informed healthcare professionals events type 1 diabetes 82 type 2 diabetes 69 conclusions nonsevere hypoglycaemia common adults insulintreated diabetes uk consequent healthrelatedeconomic effects communication nonsevere hypoglycaemia limited burden hypoglycaemia may underestimated